Skip to main content
SpringerLink
Log in

An 8-week, open-label study to evaluate the effect of sertraline on the polysomnogram of depressive patients with insomnia

  • Original Article
  • Published:
Sleep and Biological Rhythms Aims and scope Submit manuscript

Abstract

We want to evaluate the effect of sertraline on polysomnogram (PSG) and clinical variables in depression. An 8-week and open-label trial (n = 31) was applied. The primary outcome was mean baseline-to-visit changes in PSG variables. The secondary outcomes were clinical improvement, side-effects, and the subjective sleepiness. Rapid eye movement (REM) latency was prolonged significantly over the course of the study. The arousal index reached the highest level on the 1st day (13.8 _ 7.2). From the 14th day onward, the sleep latency (SL) and wake after sleep onset (WASO) decreased significantly. The percentage of stage 3 sleep increased in this trial. The Hamilton Rating Scale for Depression (HRSD) and Clinical Global Impression (CGI) scores on the 14th, 28th, and 56th days were significantly lower than baseline. Furthermore, a significant correlation was shown between the decreasing score rate of HRSD on the 56th day and the decreasing score rate of REM latency on the 1st day (r = -0.733, P = 0.003). The effectiveness of sertraline positively correlated with the reduction of REM latency. The final clinical improvement could be predicted by the extent of the prolongation of REM latency on the first night.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin. Psychol. Rev. 2007; 27 (8): 959–85.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Reynolds CF, 3rd, Kupfer DJ. Sleep research in affective illness: state of the art circa 1987. Sleep 1987; 10 (3): 199–215.

    PubMed  Google Scholar 

  3. Rush AJ, Giles DE, Jarrett RB et al. Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol. Psychiatry 1989; 26 (1): 61–72.

    Article  CAS  PubMed  Google Scholar 

  4. Cartwright R, Baehr E, Kirkby J, Pandi-Perumal SR, Kabat J. REM sleep reduction, mood regulation and remission in untreated depression. Psychiatry Res. 2003; 121 (2): 159–67.

    Article  PubMed  Google Scholar 

  5. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int. Clin. Psychopharmacol. 2006; 21 (Suppl 1): S11–15.

    Article  PubMed  Google Scholar 

  6. Kostrzewa RM, Kostrzewa JP, Kostrzewa RA, Kostrzewa FP, Brus R, Nowak P. Stereotypic progressions in psychotic behavior. Neurotox. Res. 2011; 19 (2): 243–52.

    Article  PubMed  Google Scholar 

  7. McNamara P, Auerbach S, Johnson P, Harris E, Doros G. Impact of REM sleep on distortions of self-concept, mood and memory in depressed/anxious participants. J. Affect. Disord. 2010; 122 (3): 198–207.

    Article  PubMed  Google Scholar 

  8. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J. Psychiatry Neurosci. 2007; 32 (2): 86–102.

    PubMed  PubMed Central  Google Scholar 

  9. Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim. Care Companion J. Clin. Psychiatry 2001; 3 (1): 22–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Vasar V, Appelberg B, Rimon R, Selvaratnam J. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers. Int. Clin. Psychopharmacol. 1994; 9 (3): 203–6.

    Article  CAS  PubMed  Google Scholar 

  11. Wilson S, Argyropoulos S. Antidepressants and sleep: a qualitative review of the literature. Drugs 2005; 65 (7): 927–47.

    Article  CAS  PubMed  Google Scholar 

  12. Feige B, Voderholzer U, Riemann D, Dittmann R, Hohagen F, Berger M. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology 2002; 26 (2): 246–58.

    Article  CAS  PubMed  Google Scholar 

  13. Shen J, Shapiro C. Polysomnographic sleep effects of fluoxetine and nefazodone on a seasonal affective disorder patient. Sleep Med. 2002; 3 (6): 527–8.

    Article  PubMed  Google Scholar 

  14. Monti JM, Jantos H. A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat. Int. J. Neuropsychopharmacol. 2005; 8 (1): 75–86.

    Article  CAS  PubMed  Google Scholar 

  15. Lawrence RW. Effect of mirtazapine versus fluoxetine on “sleep quality”. J. Clin. Psychiatry 2004; 65 (8): 1149–50.

    Article  PubMed  Google Scholar 

  16. Monaca C, Boutrel B, Hen R, Hamon M, Adrien J. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology 2003; 28 (5): 850–6.

    CAS  PubMed  Google Scholar 

  17. Lawlor BA, Newhouse PA, Balkin TJ et al. A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers. Biol. Psychiatry 1991; 29 (3): 281–6.

    Article  CAS  PubMed  Google Scholar 

  18. Heym J, Koe BK. Pharmacology of sertraline: a review. J. Clin. Psychiatry 1988; 49 (Suppl): 40–5.

    PubMed  Google Scholar 

  19. Jindal RD, Friedman ES, Berman SR, Fasiczka AL, Howland RH, Thase ME. Effects of sertraline on sleep architecture in patients with depression. J. Clin. Psychopharmacol. 2003; 23 (6): 540–8.

    Article  CAS  PubMed  Google Scholar 

  20. First MB, Spitzer RL, Gibbon M, Williams JBW. User’s guide for the structured clinical interview for DSM-IV axis I disorders: SCID-II clinician version: American Psychiatric Association; 1996.

    Google Scholar 

  21. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986; 9 (4): 519–24.

    CAS  PubMed  Google Scholar 

  23. Iber C, Ancoli-Israel S, Cheeson A, Quan SF for the academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 1st edn. American Academy of Sleep Medicine: Westchester, IL, 2007.

    Google Scholar 

  24. Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 2007; 4 (7): 28–37.

    Google Scholar 

  25. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. DEW: Rockville, 1976.

    Google Scholar 

  26. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28 (2): 193–213.

    Article  CAS  PubMed  Google Scholar 

  27. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992; 15 (4): 376–81.

    CAS  PubMed  Google Scholar 

  28. Le Bon O, Staner L, Hoffmann G et al. The first-night effect may last more than one night. J. Psychiatr. Res. 2001; 35 (3): 165–72.

    Article  PubMed  Google Scholar 

  29. Heiligenstein JH, Faries DE, Rush AJ et al. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Res. 1994; 52 (3): 327–39.

    Article  CAS  PubMed  Google Scholar 

  30. Keck PE Jr, Hudson JI, Dorsey CM, Campbell PI. Effect of fluoxetine on sleep. Biol. Psychiatry 1991; 29 (6): 618–19.

    Article  PubMed  Google Scholar 

  31. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH. Sleep and treatment prediction in endogenous depression. Am. J. Psychiatry 1981; 138 (4): 429–34.

    CAS  PubMed  Google Scholar 

  32. Dorsey CM, Lukas SE, Cunningham SL. Fluoxetineinduced sleep disturbance in depressed patients. Neuropsychopharmacology 1996; 14 (6): 437–42.

    Article  CAS  PubMed  Google Scholar 

  33. Vogel GW, Vogel F, McAbee RS, Thurmond AJ. Improvement of depression by REM sleep deprivation. New findings and a theory. Arch. Gen. Psychiatry 1980; 37 (3): 247–53.

    Article  CAS  PubMed  Google Scholar 

  34. Gillin JC, Sitaram N. Rapid eye movement (REM) sleep: cholinergic mechanisms. Psychol. Med. 1984; 14 (3): 501–6.

    Article  CAS  PubMed  Google Scholar 

  35. Nofzinger EA, Reynolds CF 3rd, Thase ME et al. REM sleep enhancement by bupropion in depressed men. Am. J. Psychiatry 1995; 152 (2): 274–6.

    Article  CAS  PubMed  Google Scholar 

  36. Rush AJ, Armitage R, Gillin JC et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol. Psychiatry 1998; 44 (1): 3–14.

    Article  CAS  PubMed  Google Scholar 

  37. Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004; 27 (7): 1255–73.

    PubMed  Google Scholar 

  38. Lorenzo JL, Barbanoj MJ. [Monoaminergic selectivity of the antidepressive drugs and sleep: neurophysiological implications of depression]. Rev. Neurol. 2000; 30 (2): 191–4.

    CAS  PubMed  Google Scholar 

  39. Kluge M, Schussler P, Steiger A. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Eur. Neuropsychopharmacol. 2007; 17 (8): 527–31.

    Article  CAS  PubMed  Google Scholar 

  40. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol. Psychiatry 2005; 58 (6): 510–4.

    Article  CAS  PubMed  Google Scholar 

  41. Schroder CM, O’Hara R. Depression and obstructive sleep apnea (OSA). Ann. Gen. Psychiatry 2005; 4: 13.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Fava M, Hoog SL, Judge RA, Kopp JB, Nilsson ME, Gonzales JS. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia. J. Clin. Psychopharmacol. 2002; 22 (2): 137–47.

    Article  CAS  PubMed  Google Scholar 

  43. Kajimura N, Kato M, Sekimoto M et al. A polysomnographic study of sleep patterns in normal humans with low- or high-anxiety personality traits. Psychiatry Clin. Neurosci. 1998; 52 (3): 317–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Guang Dong Mental Health Center, Guang Dong General Hospital, Guang Dong Academy of Medical Sciences, no. 123, Hui Fu Xi Road, 510120, Guang Zhou, China

    Bin Zhang, Xueli Li & Wuhan Liu

  2. Department of Human Anatomy, Guang Zhou Medical University, China

    Yanli Hao

  3. Mental Hospital of Guang Dong Civil Administration, Guang Zhou, China

    Ping Zhou

  4. Zhongshan The Third People’s Hospital, Zhong Shan, China

    Yanzhen Ren

Authors
  1. Bin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanli Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xueli Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanzhen Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ping Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wuhan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bin Zhang.

Additional information

These authors equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, B., Hao, Y., Li, X. et al. An 8-week, open-label study to evaluate the effect of sertraline on the polysomnogram of depressive patients with insomnia. Sleep Biol. Rhythms 11, 165–175 (2013). https://doi.org/10.1111/sbr.12015

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1111/sbr.12015

Search

Navigation